Barclays’s Epizyme, Inc EPZM Stock Holding History

Barclays’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-27,000	Closed	-$366K	–	7515
2018 Q2	$366K	Buy	+27,000	New	+$420K	﹤0.01%	4220

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Barclays's EPZM Position: Q3 2022 in Review

Barclays sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 105 shares.

Barclays first reported a position in EPZM in Q2 2013 and held it in 37 quarters. The position peaked at $1.95M in Q4 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Barclays reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Barclays sold 105 Epizyme, Inc shares in Q3 2022.
Barclays first reported a position in Epizyme, Inc in Q2 2013 and held it in 37 quarters.
Barclays's Epizyme, Inc position peaked at $1.95M in Q4 2019.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.